172 related articles for article (PubMed ID: 3060794)
1. Meth A fibrosarcoma cells express two transforming mutant p53 species.
Eliyahu D; Goldfinger N; Pinhasi-Kimhi O; Shaulsky G; Skurnik Y; Arai N; Rotter V; Oren M
Oncogene; 1988 Sep; 3(3):313-21. PubMed ID: 3060794
[TBL] [Abstract][Full Text] [Related]
2. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.
Rovinski B; Benchimol S
Oncogene; 1988 May; 2(5):445-52. PubMed ID: 3287278
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
Hinds PW; Finlay CA; Quartin RS; Baker SJ; Fearon ER; Vogelstein B; Levine AJ
Cell Growth Differ; 1990 Dec; 1(12):571-80. PubMed ID: 2288874
[TBL] [Abstract][Full Text] [Related]
4. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene.
Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Konishi M; Kawashima I; Takamoto S; Hirai H; Miyaki M
Oncogene; 1995 Oct; 11(7):1339-45. PubMed ID: 7478555
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion.
Tuck SP; Crawford L
Oncogene Res; 1989; 4(2):81-96. PubMed ID: 2654816
[TBL] [Abstract][Full Text] [Related]
6. Transforming activity of mutant human p53 alleles.
Slingerland JM; Benchimol S
J Cell Physiol; 1991 Sep; 148(3):391-5. PubMed ID: 1918170
[TBL] [Abstract][Full Text] [Related]
7. Frequent p53 mutations in chemically induced murine fibrosarcoma.
Halevy O; Rodel J; Peled A; Oren M
Oncogene; 1991 Sep; 6(9):1593-600. PubMed ID: 1923526
[TBL] [Abstract][Full Text] [Related]
8. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
Chang FL; Ling YF; Lai MD
Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cell growth mediated by plasmids encoding p53 anti-sense.
Shohat O; Greenberg M; Reisman D; Oren M; Rotter V
Oncogene; 1987; 1(3):277-83. PubMed ID: 2455263
[TBL] [Abstract][Full Text] [Related]
10. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
[TBL] [Abstract][Full Text] [Related]
11. The properties of p53 proteins selected for the loss of suppression of transformation.
Olson DC; Levine AJ
Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
[TBL] [Abstract][Full Text] [Related]
12. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction of wild-type and mutant p53 transfected into human tumor cell lines carrying activated ras genes.
Sharma S; Schwarte-Waldhoff I; Oberhuber H; Schäfer R
Cell Growth Differ; 1993 Oct; 4(10):861-9. PubMed ID: 8274455
[TBL] [Abstract][Full Text] [Related]
14. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
Thomas S; Reisman D
Cancer Lett; 2006 Aug; 240(1):48-59. PubMed ID: 16236433
[TBL] [Abstract][Full Text] [Related]
15. Specific overexpression of P53 in sarcoma derived from Rat-1 cells transformed by cigarette smoking condensate-treated human fetal lung DNA.
Li ZQ; Wei HJ; Luo XM; Liu XY; Chen ZG; Dai JW; Feng YM
J Environ Pathol Toxicol Oncol; 1994; 13(3):187-90. PubMed ID: 7722886
[TBL] [Abstract][Full Text] [Related]
16. Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.
Fan H; Villegas C; Huang A; Wright JA
Cancer Res; 1996 Oct; 56(19):4366-9. PubMed ID: 8813126
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135).
Yam JW; Zheng JY; Hsiao WL
Biochem Biophys Res Commun; 1999 Dec; 266(2):472-80. PubMed ID: 10600527
[TBL] [Abstract][Full Text] [Related]
18. [Isolation and characteristics of clones complementary to mRNA of the murine cellular tumor antigen p53].
Chumakov PM; Iotsova VS; Ninkina NN; Bukhman VL; Georgiev GP
Genetika; 1988 Apr; 24(4):602-12. PubMed ID: 2840339
[TBL] [Abstract][Full Text] [Related]
19. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency.
Tiemann F; Deppert W
Oncogene; 1994 Jul; 9(7):1907-15. PubMed ID: 8208537
[TBL] [Abstract][Full Text] [Related]
20. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B.
Yam JW; Chan KW; Hsiao WL
Oncogene; 2001 Jan; 20(1):58-68. PubMed ID: 11244504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]